| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 703315 | Null | 0.0396077140933377 | 0.013399262 |
| NSC 703318 | Null | 0.0396077140933377 | -0.097648957 |
| NSC 707465 | 2-Butenoic acid, 4-[[4,5-dichloro-2-[[[[2-(1-pyrrolidinyl)cyclohexyl] (methyl)amino]carbonyl]methyl]phenyl]amino]-4-oxo-, methyl ester, (1S,2S)- | 0.0396077140933377 | 0.26254144 |
| NSC 708416 | Null | 0.0396077140933377 | 0.12608889 |
| NSC 716281 | Null | 0.0396077140933377 | 0.085235591 |
| NSC 736079 | 4-[(Z)-2-(5-nitro-thiophen-2-yl)ethenyl]-6-pyrrolidin-1-yl-1 ,3,5-triazin-2-ylamine | 0.0396077140933377 | 0.15511822 |
| NSC 109084 | Null | 0.039607714093338 | 0.21132311 |
| NSC 117281 | ANTINEOPLASTIC-117281 | 0.039607714093338 | 0.27057068 |
| NSC 131257 | Null | 0.0403978426119736 | 0.11286432 |
| NSC 347217 | Carbamic acid, [5-amino-1,2-dihydro-3-(2-naphthalenyl)pyrido[3,4-b]pyrazin-7-yl]-, ethyl ester, monohydrochloride | 0.0403978426119736 | 0.0073643864 |